Volozhantsev N, Makarova M, Kartseva A, Silkina M, Krasilnikova V, Denisenko E
Antibiotics (Basel). 2025; 14(1).
PMID: 39858330
PMC: 11761230.
DOI: 10.3390/antibiotics14010044.
Taha M, Elkolaly R, Elhendawy M, Elatrozy H, Amer A, Helal R
Microorganisms. 2025; 12(12.
PMID: 39770672
PMC: 11728040.
DOI: 10.3390/microorganisms12122469.
Su Z, Zhang W, Shi Y, Cui T, Xu Y, Yang R
Sci Adv. 2024; 10(51):eadp3954.
PMID: 39705367
PMC: 11661456.
DOI: 10.1126/sciadv.adp3954.
Moradi F, Akbari M, Vakili-Ghartavol R, Ostovari M, Hadi N
Heliyon. 2024; 10(17):e36858.
PMID: 39263100
PMC: 11388783.
DOI: 10.1016/j.heliyon.2024.e36858.
Yomogida D, Kuwano H, Miyakoshi T, Mizuta S, Horikawa S, Koshida Y
Cureus. 2024; 16(4):e59094.
PMID: 38800315
PMC: 11128319.
DOI: 10.7759/cureus.59094.
Molecular detection of Class 1, 2, and 3 integrons in hypervirulent and classic isolates: A cross-sectional study.
Farajzadeh Sheikh A, Abdi M, Farshadzadeh Z
Health Sci Rep. 2024; 7(5):e1962.
PMID: 38698788
PMC: 11063457.
DOI: 10.1002/hsr2.1962.
Virulence Factors and Carbapenem-Resistance Mechanisms in Hypervirulent .
Liao Y, Gong J, Yuan X, Wang X, Huang Y, Chen X
Infect Drug Resist. 2024; 17:1551-1559.
PMID: 38660055
PMC: 11042477.
DOI: 10.2147/IDR.S461903.
Liver, lung, muscle, and bone: invasive liver abscess syndrome in a Vietnamese immigrant.
Morihara C, Du W, Benavente K, Shimamoto R
IDCases. 2023; 34:e01893.
PMID: 37711882
PMC: 10498160.
DOI: 10.1016/j.idcr.2023.e01893.
Occurrence and Molecular Study of Hypermucoviscous/Hypervirulence Trait in Gut Commensal from Healthy Subjects.
Osama D, Zaki B, Khalaf W, Yousry A Mohamed M, Tawfick M, Amin H
Microorganisms. 2023; 11(3).
PMID: 36985277
PMC: 10059952.
DOI: 10.3390/microorganisms11030704.
Antimicrobial Resistance Pattern, Pathogenicity and Molecular Properties of Hypervirulent (hvKp) among Hospital-Acquired Infections in the Intensive Care Unit (ICU).
Alharbi M, Almuhayawi M, Nagshabandi M, Tarabulsi M, Alruhaili M, Gattan H
Microorganisms. 2023; 11(3).
PMID: 36985234
PMC: 10052956.
DOI: 10.3390/microorganisms11030661.
Virulence analysis and antibiotic resistance of Klebsiella pneumoniae isolates from hospitalised patients in Poland.
Kot B, Piechota M, Szweda P, Mitrus J, Wicha J, Gruzewska A
Sci Rep. 2023; 13(1):4448.
PMID: 36932105
PMC: 10023695.
DOI: 10.1038/s41598-023-31086-w.
Recombinase-Aided Amplification Assay for Rapid Detection of Hypervirulent Klebsiella pneumoniae (hvKp) and Characterization of the hvKp Pathotype.
Yan C, Zhou Y, Du S, Du B, Zhao H, Feng Y
Microbiol Spectr. 2023; :e0398422.
PMID: 36912637
PMC: 10100362.
DOI: 10.1128/spectrum.03984-22.
Emergence of Carbapenemase-Producing Hypervirulent Klebsiella pneumoniae in Switzerland.
Raro O, Nordmann P, Dominguez Pino M, Findlay J, Poirel L
Antimicrob Agents Chemother. 2023; 67(3):e0142422.
PMID: 36853006
PMC: 10019205.
DOI: 10.1128/aac.01424-22.
Bacteriological characteristics of hypervirulent gene (hvKp-)-harboring strains in the south of Iran.
Shoja S, Ansari M, Bengar S, Rafiei A, Shamseddin J, Alizade H
Iran J Microbiol. 2023; 14(4):475-483.
PMID: 36721517
PMC: 9867641.
DOI: 10.18502/ijm.v14i4.10233.
Risk factors and molecular epidemiology of fecal carriage of carbapenem resistant Enterobacteriaceae in patients with liver disease.
Tian F, Li Y, Wang Y, Yu B, Song J, Ning Q
Ann Clin Microbiol Antimicrob. 2023; 22(1):10.
PMID: 36710337
PMC: 9884424.
DOI: 10.1186/s12941-023-00560-8.
Antibiotic Resistance, Molecular Characteristics and Risk Factors of Carbapenem-Resistant in Clinical Isolates.
Zhu J, Chen Y, Yang X
Infect Drug Resist. 2022; 15:6671-6680.
PMID: 36411757
PMC: 9675329.
DOI: 10.2147/IDR.S383010.
The making of hypervirulent Klebsiella pneumoniae.
Dai P, Hu D
J Clin Lab Anal. 2022; 36(12):e24743.
PMID: 36347819
PMC: 9757020.
DOI: 10.1002/jcla.24743.
Genetic characterization of hypervirulent responsible for acute death in captive marmosets.
Pinpimai K, Banlunara W, Roe W, Dittmer K, Biggs P, Tantilertcharoen R
Front Vet Sci. 2022; 9:940912.
PMID: 36016808
PMC: 9397405.
DOI: 10.3389/fvets.2022.940912.
Emergence of Hypervirulent ST11-K64 Poses a Serious Clinical Threat in Older Patients.
Wei T, Zou C, Qin J, Tao J, Yan L, Wang J
Front Public Health. 2022; 10:765624.
PMID: 35309213
PMC: 8930914.
DOI: 10.3389/fpubh.2022.765624.
Molecular Epidemiological Analysis of ST11-K64 Extensively Drug-Resistant Infections Outbreak in Intensive Care and Neurosurgery Units Based on Whole-Genome Sequencing.
Xiong L, Su L, Tan H, Zhao W, Li S, Zhu Y
Front Microbiol. 2021; 12:709356.
PMID: 34646245
PMC: 8504482.
DOI: 10.3389/fmicb.2021.709356.